| Comprehensive molecular characterization of clear cell renal cell carcinoma Cancer Genome Atlas Research Network Analysis working group: Baylor College ... Nature 499 (7456), 43-49, 2013 | 3860* | 2013 |
| Tumor mutational load predicts survival after immunotherapy across multiple cancer types RM Samstein, CH Lee, AN Shoushtari, MD Hellmann, R Shen, ... Nature genetics 51 (2), 202-206, 2019 | 3510 | 2019 |
| Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients A Zehir, R Benayed, RH Shah, A Syed, S Middha, HR Kim, P Srinivasan, ... Nature medicine 23 (6), 703-713, 2017 | 3254 | 2017 |
| The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ... Cell reports 23 (1), 313-326. e5, 2018 | 926 | 2018 |
| The somatic genomic landscape of chromophobe renal cell carcinoma CF Davis, CJ Ricketts, M Wang, L Yang, AD Cherniack, H Shen, C Buhay, ... Cancer cell 26 (3), 319-330, 2014 | 872 | 2014 |
| Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures Y Şenbabaoğlu, RS Gejman, AG Winer, M Liu, EM Van Allen, ... Genome biology 17, 1-25, 2016 | 862 | 2016 |
| The head and neck cancer immune landscape and its immunotherapeutic implications R Mandal, Y Şenbabaoğlu, A Desrichard, JJ Havel, MG Dalin, N Riaz, ... JCI insight 1 (17), e89829, 2016 | 755 | 2016 |
| An integrated metabolic atlas of clear cell renal cell carcinoma AA Hakimi, ED Reznik, CH Lee, CJ Creighton, AR Brannon, A Luna, ... Cancer cell 29 (1), 104-116, 2016 | 726 | 2016 |
| Integrated proteogenomic characterization of clear cell renal cell carcinoma DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ... Cell 179 (4), 964-983. e31, 2019 | 599 | 2019 |
| Mitochondrial DNA copy number variation across human cancers E Reznik, ML Miller, Y Şenbabaoğlu, N Riaz, J Sarungbam, SK Tickoo, ... elife 5, e10769, 2016 | 486 | 2016 |
| Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients B Nguyen, C Fong, A Luthra, SA Smith, RG DiNatale, S Nandakumar, ... Cell 185 (3), 563-575. e11, 2022 | 445 | 2022 |
| Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network AA Hakimi, I Ostrovnaya, B Reva, N Schultz, YB Chen, M Gonen, H Liu, ... Clinical Cancer Research 19 (12), 3259-3267, 2013 | 408 | 2013 |
| Multilevel genomics-based taxonomy of renal cell carcinoma F Chen, Y Zhang, Y Şenbabaoğlu, G Ciriello, L Yang, E Reznik, B Shuch, ... Cell reports 14 (10), 2476-2489, 2016 | 364 | 2016 |
| Complications of radical and partial nephrectomy in a large contemporary cohort AJ Stephenson, AA Hakimi, ME Snyder, P Russo The Journal of urology 171 (1), 130-134, 2004 | 359 | 2004 |
| Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors C Valero, M Lee, D Hoen, K Weiss, DW Kelly, PS Adusumilli, PK Paik, ... Nature communications 12 (1), 729, 2021 | 333 | 2021 |
| Tumor microenvironment dynamics in clear-cell renal cell carcinoma L Vuong, RR Kotecha, MH Voss, AA Hakimi Cancer discovery 9 (10), 1349-1357, 2019 | 323 | 2019 |
| Grade-dependent metabolic reprogramming in kidney cancer revealed by combined proteomics and metabolomics analysis HI Wettersten, AA Hakimi, D Morin, C Bianchi, ME Johnstone, ... Cancer research 75 (12), 2541-2552, 2015 | 312 | 2015 |
| Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival LGT Morris, N Riaz, A Desrichard, Y Şenbabaoğlu, AA Hakimi, V Makarov, ... Oncotarget 7 (9), 10051, 2016 | 311 | 2016 |
| Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations CA Karlo, PL Di Paolo, J Chaim, AA Hakimi, I Ostrovnaya, P Russo, ... Radiology 270 (2), 464-471, 2014 | 299 | 2014 |
| ClearCode34: a prognostic risk predictor for localized clear cell renal cell carcinoma SA Brooks, AR Brannon, JS Parker, JC Fisher, O Sen, MW Kattan, ... European urology 66 (1), 77-84, 2014 | 294 | 2014 |
